Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of Ezetimibe on Postprandial Hyperlipidemia and Endothelial Dysfunction in Patients With the Metabolic Syndrome.

NCT00189085 is registered in ClinicalTrials.gov with UMC Utrecht as lead sponsor.

NCT NCT00189085
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00189085 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of Ezetimibe on Postprandial Hyperlipidemia and Endothelial Dysfunction in Patients With the Metabolic Syndrome.
Lead sponsor
UMC Utrecht
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2004
Completion date
July 31, 2005
Enrollment
20
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metabolic syndrome